Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000262

Drug Information
NameClofibrate    
SynonymsELPI; Normet; BIDD:GT0172; NCGC00093755-06; KBio3_000594; DB00636; KBioGR_000885; HMS2093G07; Ethyl alpha-p-chlorophenoxyisobutyrate; Recolip; CBiol_001860; Regelan N; C12H15ClO3; EINECS 211-277-4; Lipomid; KBio2_002215; Atrovis; HMS1791O19; er; NCGC00093755-04; Skerolip; NCI60_041748; Clofibratum [INN-Latin]; Sklerepmexe; Atromid-S, Clofibrate; MolPort-000-145-477; Angiokapsul; Regardin; Novofibrate; WLN: GR DOX1&1&VO2; AY-61123; EU-0100306; BML2-F02; Clofar; ICI 28257; HMS2089P03; HSDB 3038; NSC 79389; ICI-28257; Deliva; Amotril S; NCGC00093755-05; Lipavlon; BIDD:PXR0178; Azionyl; NCGC00093755-03; Spectrum2_001209; Clofibrate [USAN:INN:BAN:JAN]; KBio1_000926; Ethyl alpha-(4-chlorophenoxy)isobutyrate; Delipid; Atheromide; UNII-HPN91K7FU3; Ethyl 2-(4-chlorophenoxy)isobutyrate; Spectrum_001735; Clofibric Acid, Ethyl Ester; BSPBio_001577; KBio2_000297; KBio2_004783; Yoclo; HMS502J04; CHEMBL565; Oxan 600; Apolan; Ateculon; SMR000058279; Cartagyl; Antilipid; Bio1_000146; Clobrat; Clobren-5F; Ethyl-alpha-p-chlorophenoxy-isobutyrate; D002994; AC1L1EHK; Citiflus; KBio3_000593; Atromida; Antilipide; Xyduril; Athranid-wirkstoff; C06916; Bio1_000635; DivK1c_000926; ZINC00056648; Chlorophenoxyisobutyrate, Ethyl; BRN 1913459; SPBio_000998; Clofinit; CPIB; Bioscleran; Robigram; Klofibrat; Sklero-tablinene; Sklero-Tablinen; clofibrate; Lipamid; Clofipront; Lopac-C-6643; Liposid; Anparton; HMS1989O19; Cinnarizin; DivK1c_000822; Bresit; KBio2_002865; NCGC00015257-09; Miskleron; Spectrum5_001133; KBioSS_002215; HMS1361O19; MLS001336012; IDI1_000822; Arterosol; Liponorm; IDI1_000926; TL8004467; Athebrate; Persantinat; Sklero; Ethyl 2-(p-chlorophenoxy)isobutyrate; Ethyl chlorophenoxyisobutyrate; KBioGR_000297; Lobetrin; Ethyl para-chlorophenoxyisobutyrate; Lipidsenker; KBio2_007351; Lipide 500; Spectrum4_000223; CCRIS 177; KBioSS_000297; KBio2_005433; Gerastop; Misclerone; Arterioflexin; Clofibram; Liprinal; Claripex; NINDS_000926; Neo-Atromid; CHEBI:3750; Amotril; Hyclorate; Chlorfenisate; S1820_Selleck; NINDS_000822; 637-07-0; Miscleron; NSC79389; Negalip; Lipofacton; Ateriosan; Vincamin compositum; Clofibate; Liporil; Ethyl clofibrate; EPIB; Dura clofibrat; Normolipol; LS-7282; BCBcMAP01_000104; Liprin; Levatrom; ATROMID-S (TN); UPCMLD-DP019:001; NCGC00093755-08; MLS001336011; NCGC00093755-01; Artevil; Chlorphenisate; KBio1_000822; Lipavil; Ethyl p-chlorophenoxyisobutyrate; Normat; neo-Atomid; Regelan; Atromid; Sklero-tabuls; Serotinex; Fibralem; Athromidin; Scrobin; C 6643; Liporeduct; Sklerolip; NCGC00015257-01; MLS002153494; UPCMLD-DP019; Clofibrato [Spanish]; Bio1_001124; Clobren-SF; NCGC00015257-02; NCGC00093755-07; Skleromex; NCIOpen2_004739; Atheropront; clofibrate (CLOF); ST50319977; Clofibrat; I01-1842; Ethyl alpha-(p-chlorophenoxy)isobutyrate; Normalip; Bio2_000297; Serofinex; Clofibratum; nchembio790-comp25; Klofiran; Claripex CPIB; NSC-79389; Atromid S; Bio2_000777; HMS502O08; Atromidin; IDI1_034047; D00279; 19 more names available; Cloberat; Skleromexe; Lopac0_000306; AC1Q3200; AY 61123; Clofibrate (JP15/USP/INN); Atrolen; Clofibrato; Atromid-S; Ticlobran; Clofibrato [INN-Spanish]; CID2796; C6643_SIGMA    
Trade NameAtromid-S    
CompanyAyerst Laboratories Inc    
IndicationDysbetalipoproteinemiaApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntilipemic Agents    
CAS NumberCAS 637-07-0
FormularC12H15ClO3    
PubChem Compound IDCID 2796.    
PubChem Substance IDSID 9133.    
ChEBI3750;    
SuperDrug ATC IDC10AB01;    
SuperDrug CAS ID000637070;    
TargetLipoprotein lipaseActivator[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 070531 To Reference
Ref 2Effects of clofibrate treatment in laying hens. Poult Sci. 2007 Jun;86(6):1187-95. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543